Low-Barrier

The goal of this research project is to understand how HIV infection and antiretroviral therapy affect adipose tissue dysfunction in people living with HIV (PWH). Adipose tissue dysfunction in PWH can lead to metabolic complications like cardiovascular disease, fatty liver disease, and diabetes. The project aims to achieve two specific objectives:

Stimulant use and associated sequelae have been rising, representing not only a public health crisis in of itself but also a major barrier to successful control of the HIV epidemic.